Mr. Chirico has nearly 40 years of accomplishments directing the product development, clinical studies, marketing and sales for various medical companies in the global marketplace. He currently is the President, CEO & Co-Founder of Silver Bullet Therapeutics, Inc., San Jose, CA, which is a company that has developed and is beginning commercialization of antimicrobial orthopedic implants for the prevention of bone based infections. Mr. Chirico is also the Executive Chairman for SpineAlign Medical, Inc. where he was the inventor, founder and previous CEO. SpineAlign Medical is a commercial stage medical device company dedicated to the design, development and successful commercialization of minimally-invasive surgical products for spine procedures. Prior to SpineAlign Medical, Mr. Chirico has many years of directing the marketing and new product development for several companies that include Micrus Endovascular Corporation, Aesculap Instruments Corporation and Avocet Medical. Previously, Mr. Chirico also supported all clinical trials for Bristol Laboratories related to chemotherapy, anti-infectives and analgesia products. He also completed a full preceptorship in infectious disease at Duke University. Paul also directed the investor relations and corporate marketing for Incyte Genomics. Paul holds a B.S. Biological Sciences, an M.B.A. from the University of Santa Clara and has several patents and publications.